1-tert-butyl 3-methyl 5-methylpiperidine-1,3-dicarboxylate, 95.0%, 10g

(R)-2-Methylmorpholine, 95.0%, 100mg

4-((S)-1-((1S,3aS,7aS,E)-4-((Z)-2-((3S,5R)-3,5-bis((tert-butyldimethylsilyl)oxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)ethoxy)-2-methylbutan-2-ol, 97%, 50mg

(R)-tert-Butyl (2-oxoazepan-3-yl)carbamate, 95.0%, 25g

Benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate, 98.0%, 100g

5-(Hydroxyimino)pyrimidine-2,4,6(1H,3H,5H)-trione hydrate, 95.0%, 100g

4-Bromo-N-(2,5-diethoxyphenyl)benzenesulfonamide, 97%, 1g

6-[4-(3-Chlorophenyl)piperazin-1-yl]-3-cyclohexyl-1,2,3,4-tetrahydropyrimidine-2,4-dione, 98.0%, 10mg

Tetramethylsilane, min. 99.9%, for NMR spectroscopy, 25 ml, glass packaging

2,2-DIFLUOROMALONAMIDE, 95.0%, 2g

(R)-1-N-Boc-Piperazine-2-carboxylic acid, 95.0%, 250mg

2-PYRROLIDIN-2-YLPYRIDINE HCL, 95.0%, 25g

Benzo[cd]indol-2(1H)-one, 98.0%, 5g